作者: Dawn M Wahezi , Norman T Ilowite
DOI: 10.1517/14656566.2013.783569
关键词:
摘要: Introduction: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in childhood. Therapeutic advances treatment of JIA are occurring at a rapid rate, resulting more ambitious therapeutic goals and increasing numbers children experiencing complete clinical remission. Areas covered: The purpose this review to summarize available treatments for management systemic features with JIA, including current evidence supporting safety efficacy biologic agents future approaches. Expert opinion: With pharmacotherapy, physical functional outcomes have improved immensely. establishment research consortia among pediatric rheumatology community has allowed large controlled studies enabled better understanding these children. Long-term data remain limited thus longer, larger w...